AtriCure, Inc. vs. Baxter International Inc.
Baxter International Inc. (BAX) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| ATRC | BAX | |
|---|---|---|
| Market Cap | $2.91 billion | $11.90 billion |
| Revenue (TTM) | $569.62 million | $11.47 billion |
| Net Income (TTM) | $10.55 million | $-1,063,000,000 |
BAX leads on 2 of 3 size & scale factors.
Valuation
| ATRC | BAX | |
|---|---|---|
| P/E Ratio | 279.43 | — |
| Price / Book | 5.63 | 1.93 |
| Price / Sales | 5.10 | 1.04 |
BAX leads on 2 of 2 valuation factors.
Profitability
| ATRC | BAX | |
|---|---|---|
| Net Margin | 1.85% | -9.27% |
| Return on Equity | 2.04% | -17.20% |
ATRC leads on 2 of 2 profitability factors.
Dividend
| ATRC | BAX | |
|---|---|---|
| Dividend Yield | — | 0.18% |
ATRC and BAX split the dividend factors evenly.
Risk & Sentiment
| ATRC | BAX | |
|---|---|---|
| Short Interest | 3.87% | 1.03% |
BAX leads on 1 of 1 risk & sentiment factors.
Dig deeper: ATRC overview, ATRC financials, BAX overview, BAX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.